For the past 50 years, the Crohn’s & Colitis Foundation of America has worked to improve the lives of patients living with Crohn’s disease and ulcerative colitis, and to find cures for these debilitating digestive diseases. Today, the Foundation unveiled its new brand, which includes a new brand message, “uniting to care and cure,” and a new logo with a unifying symbol reflecting the organization’s commitment to the IBD community. In addition, the Foundation has amended its name to the Crohn’s & Colitis Foundation to place greater emphasis on its mission to cure these debilitating digestive diseases.
Today, the Crohn's & Colitis Foundation announced the launch of IBD Qorus™, a ground-breaking collaboration between patients and their healthcare providers that will lead to enhanced health outcomes and improve the quality of care for inflammatory bowel disease (IBD) patients.
The Crohn’s & Colitis Foundation announced today that it was awarded $2.5 million from the Patient-Centered Outcomes Research Institute (PCORI) to study the effectiveness of the specific carbohydrate diet and Mediterranean-style diet to induce remission in patients with Crohn’s disease.
The Crohn’s & Colitis Foundation announced today the passing of co-founding member, philanthropist, entrepreneur and lawyer, Irwin M. Rosenthal. Motivated by his wife Suzanne’s struggle with Crohn’s disease, Irwin, along with William and Shelby Modell, and Dr. Henry D. Janowitz, founded the Foundation for Research in Ileitis, now known as the Crohn’s & Colitis Foundation of America. It was the combination of his tenacity, compassion and love for his wife that put the Foundation on the road to success.
NEW YORK, NY – For more than 11 million children and adults, summer camp provides an escape from every day life- a chance to enjoy the outdoors, meet new people, and participate in fun and exciting activities.